| 1 |
Skapek SX, Ferrari A, Gupta AA, et al. Rhabdomyosarcoma[J].
Nat Rev Dis Primers,
2019,
5(1): 1.
|
| 2 |
段超，张伟令，孙青，等. 儿童及青少年横纹肌肉瘤多中心临床研究——CCCG-RMS-2016方案近期疗效研究报告[J].
中国小儿血液与肿瘤杂志，
2020,
25(5): 253-257.
|
| 3 |
中国抗癌协会小儿肿瘤专业委员会，中华医学会儿科学分会血液学组，中华医学会小儿外科学分会肿瘤组. 中国儿童及青少年横纹肌肉瘤诊疗建议(CCCG-RMS-2016)[J].
中华儿科杂志，
2017，
68(10): 724-728.
|
| 4 |
Ognjanovic S, Linabery AM, Charbonneau B, et al. Trends in childhood rhabdomyosarcoma incidence and survival in the united states, 1975-2005[J].
Cancer,
2009,
115(18): 4218-4226.
|
| 5 |
Smith MA, Altekruse SF, Adamson PC, et al. Declining childhood and adolescent cancer mortality[J].
Cancer,
2014,
120(16): 2497-2506.
|
| 6 |
Crist W, Gehan EA, Ragab AH, et al. The third intergroup rhabdomyosarcoma study[J].
Journal of Clinical Oncology,
1995,
13(3): 610-630.
|
| 7 |
Maurer HM, Gehan EA, Beltangady M, et al. The intergroup rhabdomyosarcoma study-Ⅱ[J].
Cancer,
1993,
71(5): 1904-1922.
|
| 8 |
Amer KM, Thomson JE, Congiusta D, et al. Epidemiology, incidence, and survival of Rhabdomyosarcoma subtypes: SEER and ICES database analysis[J].
Journal of Orthopaedic Research,
2019,
37(10): 2226-2230.
|
| 9 |
Winston H, Daniela EB. Rhabdomyosarcoma in adolescent and young adult patients: current perspectives[J].
Adolescent Health Medicine & Therapeutics,
2014,
2014: 115-125.
|
| 10 |
Saltzman AF, Cost NG. Current treatment of pediatric bladder and prostate rhabdomyosarcoma[J].
Current Urology Reports,
2018,
19(1): 11.
|
| 11 |
纪妹. 机器人在子宫内膜癌中的应用[J/CD].
中华腔镜外科杂志(电子版),
2017,
5(10): 297-299.
|
| 12 |
Agarwal DK, Miest TS, Granberg CF, et al. Pediatric robotic prostatectomy and pelvic lymphadenectomy for embryonal rhabdomyosarcoma[J].
Urology,
2018,
119: 143-145.
|
| 13 |
Li P, Zhou H, Cao H, et al. Robot-assisted laparoscopic radical cystectomy and sigmoid orthotopic neobladder reconstruction for a bladder rhabdomyosarcoma child: case report and literature review[J].
Urology,
2020,
138: 144-147.
|
| 14 |
Anderberg M, Backman T, Annerstedt M. Robot-assisted radical cystoprostatectomy in a small child with rhabdomyosarcoma: a case report[J].
Journal of robotic surgery,
2008,
2(2): 101-103.
|
| 15 |
Cost NG, DaJusta DG, Granberg CF, et al. Robot-assisted laparoscopic retroperitoneal lymph node dissection in an adolescent population[J].
Journal of endourology,
2012,
26(6): 635-640.
|
| 16 |
Arndt C, Rodeberg D, Breitfeld PP, et al. Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma/results from intergroup rhabdomyosarcoma study iv[J].
Journal of Urology,
2004,
171(6): 2396-403.
|
| 17 |
Heyn R, Newton WA, Raney RB, et al. Preservation of the bladder in patients with rhabdomyosarcoma[J].
Journal of Clinical Oncology,
1997,
15(1): 69-75.
|
| 18 |
Buszek S, Ludmir E, Grosshans D, et al. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma[J].
Pediatric Blood & Cancer,
2019,
66(11) : 27952.
|
| 19 |
Seitz G, Dantonello TM, Int-Veen C, et al. Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: a report from the cooperative soft tissue sarcoma trial cws-96[J].
Pediatric blood & cancer,
2011,
56(5): 718-724.
|
| 20 |
Sardaro A, Carbonara R, Petruzzelli MF, et al. Proton therapy in the most common pediatric non-central nervous system malignancies: an overview of clinical and dosimetric outcomes[J].
Italian journal of pediatrics,
2019,
45(1): 1-13.
|
| 21 |
Leiser D, Calaminus G, Malyapa R, et al. Tumour control and quality of life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy[J].
Radiotherapy and Oncology,
2016,
120(1) : 163-168.
|
| 22 |
Cotter SE, Herrup DA, Friedmann A, et al.Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy[J].
International journal of radiation oncology, biology, physics，
2011，
81(5): 1367-1373.
|
| 23 |
De Laney TF, Kooy HM. Proton and charged particle radiotherapy[J].
Lippincott Williams & Wilkins,
2008，
1: 165-167.
|
| 24 |
Crist WM, Anderson JR, Meza JL, et al. Intergroup rhabdomyosarcoma study-Ⅳ：results for patients with nonmetastatic disease[J].
J Clin Oncol,
2001,
19(12): 3091-3102.
|
| 25 |
Walterhouse D, Pappo A, Meza J, et al. Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children′s oncology group[J].
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
2014,
32(31): 3547-3552.
|
| 26 |
Lerner SP, Hayani A, O'Hollaren P, et al. The role of surgery in the management of pediatric pelvic rhabdomyosarcoma[J].
J Urol,
1995,
154(2): 540-545.
|
| 27 |
Seitz G, Fuchs J, Sparber-Sauer M, et al. Improvements in the treatment of patients suffering from bladder-prostate rhabdomyosarcoma: a report from the cws-2002p trial[J].
Annals of Surgical Oncology,
2016,
23(12): 4067-4072.
|
| 28 |
Sparber-Sauer M, Stegmaier S, Vokuhl C, et al. Rhabdomyosarcoma diagnosed in the first year of life: localized, metastatic, and relapsed disease. outcome data from five trials and one registry of the cooperative weichteilsarkom studiengruppe (CWS)[J].
Pediatr Blood Cancer,
2019,
66(6): 27652.
|
| 29 |
Vaarwerk B, Lee JH, Breunis WB, et al. Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: a report from the international society of pediatric oncology malignant mesenchymal tumor 95 study[J].
Cancer,
2018,
124(5): 1016-1024.
|